Dublin, Feb. 23, 2017 -- Research and Markets has announced the addition of the "Autoimmune IVD Testing Market" report to their offering.
This report provides important business planning information for in vitro diagnostic testing products, instruments and supplies used in the detection of autoimmune disease. The report includes market sizing and forecasts, regional markets, markets by type - including arthritis, thyroid, gastrological disease, SLE, and others.
The report also details new innovations in testing and profiles companies in the market. The following companies are covered. Revenues, test product, and significant competitive moves are included: Thermo Fisher WerfenLife, Alere, Inc, HYCOR Biomedical and several other companies.
Key Topics Covered:
1: Executive Summary
Introduction
Market
Conclusions
Conclusion 1: There are vast opportunities for manufacturers of autoimmune
diagnostic testing products in the autoimmune arena
Conclusion 2: Women are disproportionately affected by autoimmune disease
Conclusion 3: Testing needs to be cost effective but precise to identify autoimmune diseases
Conclusion 4: Sophistication in testing is leading to more automated effective testing
Conclusion: 5 Proteonomic research is furthering the discovery of autoimmune disease markers
2: Introduction and Overview
Autoimmunity
Components of the Immune System
Humoral Immunity
Cell-Mediated Immunity
Types of Autoimmune Diseases
Rheumatoid Arthritis
Autoimmune Gastrointestinal Disease
Systemic Lupus Erythematosus
Autoimmune Thyroid Disease
Multiple Sclerosis
Company Financials
- Autoimmune Technologies, LLC
- Beckman Coulter (Danaher)
- Biohit Oyj
- Bio-Rad Laboratories
- Corgenix Medical Corporation
- Diamedix Corporation
- DiaSorin S.p.A
- Entopsis, LLC
- Enzo Biochem, Inc.
- ERBA Diagnostics, Inc.
- ERBA Mannheim
- Euro Diagnostica AB
- Euroimmun AG
- Exagen Diagnostics, Inc
- Gold Standard Diagnostics
- HOB Biotech Group
Autoimmune IVD Products
- Sjogren's Syndrome
- Myasthenia Gravis
- Type 1 Diabetes
Prevalence and Demographics of Autoimmune Disease
Prevalence in Women
Genetic Factors and Autoimmune Disease
Automated Autoimmune Diagnostic Platforms
Autoimmune Testing
Types of Tests
- Rheumatoid Arthritis IVD Diagnostic Tests
- Autoimmune Gastrointestinal Disease IVD Tests
- Systemic Lupus Erythematosus IVD Tests
- Autoimmune Thyroid Disease
- Multiple Sclerosis
- Sjogren's Syndrome
- Myasthenia Gravis
- Type 1 Diabetes
3: Autoimmune IVD Diagnostic Testing Market Analysis
Total Worldwide Autoimmune IVD Diagnostic Testing Market
Autoimmune IVD Diagnostic Testing Market by Disease
Autoimmune IVD Testing Market by Region
4: Autoimmune IVD Diagnostic Testing Market Players
- Adaptive Biotechnologies Corporation
- Alere, Inc
- HYCOR Biomedical
- Immunovia AB
- INOVA Diagnostics, Inc.
- Lophius BioSciences GmbH
- Luminex Corporation
- Menarini Diagnostics
- Orgentec Diagnostika GmbH
- Protagen Diagnostics
- Quanterix Corporation
- Radiometer A/S
- Selventa
- Theradiag
- Thermo Fisher Scientific, Inc.
- Trinity Biotech
- WerfenLife.
- Zeus Scientific, Inc.
For more information about this report visit http://www.researchandmarkets.com/research/brg5sf/autoimmune_ivd
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Healthcare Services, In Vitro Diagnostics


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



